Search results

Source:

electronic Medicines Compendium - eMC (Remove filter)

This information is intended for use by health professionals 1. Name of the medicinal product Coracten XL 30 mg 2. Qualitative

Type:

Prescribing and Technical Information (Remove filter)

Type:

Guidance (Add filter)

Source:

Medicines Management Collection (Remove filter)

Published by Research In Social & Administrative Pharmacy : Rsap, 12 July 2018

INTRODUCTION: While many attempts have been made to reduce prescribing errors (PEs), they persist. PE is not in itself a behaviour, but a consequence...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 July 2020

This product is now licensed for the treatment of other chronic fibrosing interstitial lung diseases with a progressive phenotype in adults. Information relating to this new indication has been added...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 July 2020

SPC updated to note that the product contains 10 microgram phenylalanine in each 0.5 ml dose which is equivalent to 0.17 microgram/kg for a 60 kg person. Phenylalanine may be harmful for people with...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 July 2020

This product is licensed for use as a substitution treatment for opioid drug dependence in individuals aged >15 years who have agreed to be treated, within a framework of medical, social and...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 30 July 2020

Observational study data on the incidence of osteonecrosis of the jaw has been added to section 4.8.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 21 July 2020

This soluble tablet formulation of hydrocortisone is licensed for; congenital adrenal hyperplasia, asthma, hypersensitivity reactions, serum sickness, angioneurotic oedema, anaphylaxis, and treatment...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 29 June 2020

SPC now recommends that, because of the possibility of reduced glucose tolerance/diabetes mellitus with topical ophthalmic corticosteroids, caution is recommended when administering maxitrol to...

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 05 August 2020

Non-serious hyper sensitivity has been added as an adverse event to SPCs.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)

Source:

electronic Medicines Compendium - eMC (Remove filter)

Published by electronic Medicines compendium, 05 August 2020

The pregnancy information in SPCs has been updated in relation to the occurrence of neural tube defects with the dolutegravir regimens.

Read Summary

Type:

Prescribing and Technical Information (Remove filter)